Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Vanz Pharm is a professional pharmaceutical company based in China that specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and fine chemical intermediates. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing custom synthesis services for small molecules and peptides. Their product catalog includes a wide range of compounds used in the treatment of metabolic disorders, cardiovascular diseases, and oncology. Wuhan Vanz Pharm supports the global life sciences industry by offering high-quality chemical building blocks from laboratory research to industrial-scale production. With a focus on R&D, the company maintains modern facilities in Wuhan to ensure rigorous quality standards for its international clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Vanz Pharm.